


Revere Pharmaceuticals
Pharmaceutical Manufacturing • United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Phone number | +17817189033 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Oncology And Drug Development |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
Key Contact at Revere Pharmaceuticals
Robert Silverman
President and CEO
About Revere Pharmaceuticals
Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rho GTPases, which play a key role in the progression of many cancers. Our lead Rac1 inhibitor is orally bioavailable and demonstrates good in vivo anti-tumor activity as a single agent in multiple tumor models. Revere has developed a suite of proprietary biochemical and cell-based assays to evaluate our small molecule inhibitors, which are optimized using structure-based drug design. Our Rho GTPase platform has enabled Revere to build a pipeline of differentiated Rho GTPase inhibitors for different cancers.
Revere Pharmaceuticals revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | $1,100,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Revere Pharmaceuticals has 1 employees across 1 departments.
Departments
Number of employees
Revere Pharmaceuticals Tech Stack
Discover the technologies and tools that power Revere Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Form builders
JavaScript libraries
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
WordPress plugins
Blogs
Analytics
Video players
SEO
Font scripts
Frequently asked questions
4.8
40,000 users



